BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33953592)

  • 1. Gastroparesis Symptoms Associated with Intestinal Hypomotility: An Explorative Study Using Wireless Motility Capsule.
    Bekkelund M; Sangnes DA; Søfteland E; Aabakken L; Biermann M; Steinsvik EK; Hausken T; Dimcevski G; Hatlebakk JG
    Clin Exp Gastroenterol; 2021; 14():133-144. PubMed ID: 33953592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit.
    Parkman HP; Sharkey E; McCallum RW; Hasler WL; Koch KL; Sarosiek I; Abell TL; Kuo B; Shulman RJ; Grover M; Farrugia G; Schey R; Tonascia J; Hamilton F; Pasricha PJ;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):546-558.e5. PubMed ID: 33130007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis.
    Hasler WL; May KP; Wilson LA; Van Natta M; Parkman HP; Pasricha PJ; Koch KL; Abell TL; McCallum RW; Nguyen LA; Snape WJ; Sarosiek I; Clarke JO; Farrugia G; Calles-Escandon J; Grover M; Tonascia J; Lee LA; Miriel L; Hamilton FA;
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28872760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal Pain in Patients with Gastroparesis: Associations with Gastroparesis Symptoms, Etiology of Gastroparesis, Gastric Emptying, Somatization, and Quality of Life.
    Parkman HP; Wilson LA; Hasler WL; McCallum RW; Sarosiek I; Koch KL; Abell TL; Schey R; Kuo B; Snape WJ; Nguyen L; Farrugia G; Grover M; Clarke J; Miriel L; Tonascia J; Hamilton F; Pasricha PJ
    Dig Dis Sci; 2019 Aug; 64(8):2242-2255. PubMed ID: 30852767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wireless motility capsule compared with scintigraphy in the assessment of diabetic gastroparesis.
    Sangnes DA; Søfteland E; Bekkelund M; Frey J; Biermann M; Gilja OH; Dimcevski G
    Neurogastroenterol Motil; 2020 Apr; 32(4):e13771. PubMed ID: 31886950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology.
    Sarosiek I; Selover KH; Katz LA; Semler JR; Wilding GE; Lackner JM; Sitrin MD; Kuo B; Chey WD; Hasler WL; Koch KL; Parkman HP; Sarosiek J; McCallum RW
    Aliment Pharmacol Ther; 2010 Jan; 31(2):313-22. PubMed ID: 19814743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Diagnostic and Performance Characteristics of the Wireless Motility Capsule in Patients With Suspected Gastroparesis.
    Lee AA; Rao S; Nguyen LA; Moshiree B; Sarosiek I; Schulman MI; Wo JM; Parkman HP; Wilding GE; McCallum RW; Hasler WL; Kuo B
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1770-1779.e2. PubMed ID: 30557741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline Predictors of Longitudinal Changes in Symptom Severity and Quality of Life in Patients With Suspected Gastroparesis.
    Lee AA; Rao K; Parkman HP; McCallum RW; Sarosiek I; Nguyen LA; Wo JM; Schulman MI; Moshiree B; Rao S; Kuo B; Hasler WL
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e407-e428. PubMed ID: 32971231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of Prokinetics, Gastroparesis Diet, or Neuromodulators Alone or in Combination for Symptoms of Gastroparesis.
    Hasler WL; Lee AA; Moshiree B; Surjanhata BC; Rao S; Parkman HP; Nguyen LA; Sarosiek I; Wo JM; Schulman MI; McCallum RW; Kuo B
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):867-877.e12. PubMed ID: 37913936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal symptoms and cardiac vagal tone in type 1 diabetes correlates with gut transit times and motility index.
    Wegeberg AL; Brock C; Ejskjaer N; Karmisholt JS; Jakobsen PE; Drewes AM; Brock B; Farmer AD
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13885. PubMed ID: 32573076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study describing peripheral neuropathy in patients with symptoms of gastroparesis: associations with etiology, gastrointestinal symptoms, and gastric emptying.
    Moors VJ; Graveran KD; Shahsavari D; Parkman HP
    BMC Gastroenterol; 2022 Jun; 22(1):315. PubMed ID: 35761166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wireless Motility Capsule: a One-Stop Shop for the Evaluation of GI Motility Disorders.
    Saad RJ
    Curr Gastroenterol Rep; 2016 Mar; 18(3):14. PubMed ID: 26908282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal rather than antral motility contractile parameters correlate with symptom severity in gastroparesis patients.
    Barshop K; Staller K; Semler J; Kuo B
    Neurogastroenterol Motil; 2015 Mar; 27(3):339-46. PubMed ID: 25521513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroparesis-Related Symptoms in Patients With Type 2 Diabetes Mellitus: Early Detection, Risk Factors, and Prevalence.
    Asghar S; Asghar S; Shahid S; Sajjad H; Abdul Nasir J; Usman M
    Cureus; 2023 Mar; 15(3):e35787. PubMed ID: 37025723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric electrical stimulation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunting of Colon Contractions in Diabetics with Gastroparesis Quantified by Wireless Motility Capsule Methods.
    Coleski R; Wilding GE; Semler JR; Hasler WL
    PLoS One; 2015; 10(10):e0141183. PubMed ID: 26510137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized transit delay on wireless motility capsule testing in patients with clinical suspicion of gastroparesis, small intestinal dysmotility, or slow transit constipation.
    Kuo B; Maneerattanaporn M; Lee AA; Baker JR; Wiener SM; Chey WD; Wilding GE; Hasler WL
    Dig Dis Sci; 2011 Oct; 56(10):2928-38. PubMed ID: 21625964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms.
    Su A; Gandhy R; Barlow C; Triadafilopoulos G
    BMJ Open Gastroenterol; 2017; 4(1):e000132. PubMed ID: 28321329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
    Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
    Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
    Shin A; Camilleri M; Busciglio I; Burton D; Smith SA; Vella A; Ryks M; Rhoten D; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.